Four major players in healthcare said today they inked a collaborative partnership to develop a phone-based, low-cost diabetes platform for Type II patients worldwide. Gentag, Mayo Clinic, NovioSense and the Fraunhofer Institute for Microelectronic Circuits and Systems will partner for the consortium, combining their resources and over 75 issued patents for the development, the groups said. “By pooling […]
